SCHEMBL4285600

SCHEMBL4285600

CN1CCN(C(=O)OC2CCN(C(=O)OCc3ccccc3)CC2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.62
NPC1 O15118 2/20 0.62
RAB9A P51151 2/20 0.62
CYP2C19 P33261 1/20 0.60
TMEM97 Q5BJF2 6/20 0.54
SIGMAR1 Q99720 6/20 0.54
HTR1A P08908 1/20 0.54
ADRA2A P08913 1/20 0.54
ADRA2B P18089 1/20 0.54
ADRA2C P18825 1/20 0.54
DRD1 P21728 1/20 0.54
HRH2 P25021 1/20 0.54
HTR1B P28222 1/20 0.54
HTR2A P28223 1/20 0.54
HTR2C P28335 1/20 0.54
HTR1E P28566 1/20 0.54
SLC6A4 P31645 1/20 0.54
HRH1 P35367 1/20 0.54
HTR2B P41595 1/20 0.54
HRH3 Q9Y5N1 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24673292 0.88 MEN1 (0.66) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL2607031 0.88 MEN1 (0.66) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL953680 0.87 PRSS1 (0.67) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL31038397 0.87 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL31452936 0.87 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL9691141 0.86 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL2306313 0.85 SMN1; SMN2 (0.70) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL16669593 0.85 MEN1 (0.76) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL13431982 0.84 SMN1; SMN2 (0.64) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL27593936 0.84 SMN1; SMN2 (0.64) SMN1; SMN2NPC1RAB9ACYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009131246-A1 SORDARIN DERIVATIVES FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS ASTELLAS PHARMA INC. (JP) 2009-10-29 WO disclosed
WO-2009131246-A1 SORDARIN DERIVATIVES FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS ASTELLAS PHARMA INC. (JP) 2009-10-29 WO disclosed